GSK will partner with Hengrui Pharma to develop up to 12 treatments for indications in respiratory, immunology and ...

Komor and Gaudelli developed the first iterations of base editing, providing the basis for engineering specific genomic base substitutions.

Sanjana discusses the large question his lab is trying to answer: "How can we efficiently identify which regions or genome drive disease?" ...

In part one, Shapiro discusses her scientific journey, her trailblazing work in ancient DNA, and updates on Colossal projects.

He described how we move forward to increase the use of CRISPR in the clinic and how to streamline the process by which this ...

New tools and delivery vehicles for CRISPR are only truly beneficial if we can simultaneously improve the affordability and access.

Large-scale study defines genetic architecture of stuttering; findings point to 48 genes associated and highlight neurological risk pathways.

Sarepta Therapeutics said it will resume shipments of its gene therapy Elevidys® (delandistrogene moxeparvovec-rokl) “imminently” to ambulant patients with Duchenne muscular dystrophy (DMD), ending a ...

Improved understanding of how bacterial defense mechanisms operate may help scientists select phages with the best chance of ...

A new physiological salt-based method enables high-resolution transcription factor mapping in small and single-cell samples.

The UAE Pangenome Reference is freely available to support research into genetic disorders, disease predisposition, and population health.

The AI model, GeneAgent, reduces hallucinations for gene-set analysis by autonomously interacting with biology databases to verify output.